- Home
- VYNE vs NEUE Comparison
VYNE vs NEUE Comparison
Compare VYNE & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- NEUE
- Stock Information
- Founded
- VYNE 2003
- NEUE 2015
- Country
- VYNE United States
- NEUE United States
- Employees
- VYNE N/A
- NEUE N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- NEUE
- Sector
- VYNE Health Care
- NEUE
- Exchange
- VYNE Nasdaq
- NEUE NYSE
- Market Cap
- VYNE 41.9M
- NEUE 42.7M
- IPO Year
- VYNE 2018
- NEUE 2021
- Fundamental
- Price
- VYNE $2.49
- NEUE $3.95
- Analyst Decision
- VYNE Strong Buy
- NEUE Hold
- Analyst Count
- VYNE 2
- NEUE 1
- Target Price
- VYNE $6.88
- NEUE $7.00
- AVG Volume (30 Days)
- VYNE 70.8K
- NEUE 9.2K
- Earning Date
- VYNE 11-07-2024
- NEUE 11-07-2024
- Dividend Yield
- VYNE N/A
- NEUE N/A
- EPS Growth
- VYNE N/A
- NEUE N/A
- EPS
- VYNE N/A
- NEUE N/A
- Revenue
- VYNE $493,000.00
- NEUE $996,890,000.00
- Revenue This Year
- VYNE $28.30
- NEUE N/A
- Revenue Next Year
- VYNE N/A
- NEUE $9.44
- P/E Ratio
- VYNE N/A
- NEUE $1.12
- Revenue Growth
- VYNE 39.27
- NEUE N/A
- 52 Week Low
- VYNE $1.57
- NEUE $3.79
- 52 Week High
- VYNE $3.43
- NEUE $16.59
- Technical
- Relative Strength Index (RSI)
- VYNE 40.82
- NEUE 31.22
- Support Level
- VYNE $2.34
- NEUE $3.99
- Resistance Level
- VYNE $2.69
- NEUE $5.18
- Average True Range (ATR)
- VYNE 0.19
- NEUE 0.35
- MACD
- VYNE -0.04
- NEUE -0.15
- Stochastic Oscillator
- VYNE 13.79
- NEUE 7.24
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.